Cargando…

Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner

BACKGROUND AND AIM: Angiogenesis is emerging as a pivotal process in chronic inflammatory pathologies, promoting immune infiltration and prompting carcinogenesis. Ulcerative Colitis (UC) and Crohn’s Disease (CD) represent paradigmatic examples of intestinal chronic inflammatory conditions in which t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarnelli, Giovanni, D’Alessandro, Alessandra, Iuvone, Teresa, Capoccia, Elena, Gigli, Stefano, Pesce, Marcella, Seguella, Luisa, Nobile, Nicola, Aprea, Giovanni, Maione, Francesco, de Palma, Giovanni Domenico, Cuomo, Rosario, Steardo, Luca, Esposito, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878779/
https://www.ncbi.nlm.nih.gov/pubmed/27219328
http://dx.doi.org/10.1371/journal.pone.0156198
_version_ 1782433609570844672
author Sarnelli, Giovanni
D’Alessandro, Alessandra
Iuvone, Teresa
Capoccia, Elena
Gigli, Stefano
Pesce, Marcella
Seguella, Luisa
Nobile, Nicola
Aprea, Giovanni
Maione, Francesco
de Palma, Giovanni Domenico
Cuomo, Rosario
Steardo, Luca
Esposito, Giuseppe
author_facet Sarnelli, Giovanni
D’Alessandro, Alessandra
Iuvone, Teresa
Capoccia, Elena
Gigli, Stefano
Pesce, Marcella
Seguella, Luisa
Nobile, Nicola
Aprea, Giovanni
Maione, Francesco
de Palma, Giovanni Domenico
Cuomo, Rosario
Steardo, Luca
Esposito, Giuseppe
author_sort Sarnelli, Giovanni
collection PubMed
description BACKGROUND AND AIM: Angiogenesis is emerging as a pivotal process in chronic inflammatory pathologies, promoting immune infiltration and prompting carcinogenesis. Ulcerative Colitis (UC) and Crohn’s Disease (CD) represent paradigmatic examples of intestinal chronic inflammatory conditions in which the process of neovascularization correlates with the severity and progression of the diseases. Molecules able to target the angiogenesis have thus the potential to synergistically affect the disease course. Beyond its anti-inflammatory effect, palmitoylethanolamide (PEA) is able to reduce angiogenesis in several chronic inflammatory conditions, but no data about its anti-angiogenic activity in colitis have been produced, yet. METHODS: The effects of PEA on inflammation-associated angiogenesis in mice with dextran sulphate sodium (DSS)-induced colitis and in patients with UC were assessed. The release of Vascular Endothelial Growth Factor (VEGF), the hemoglobin tissue content, the expression of CD31 and of phosphatidylinositol 3-kinase/Akt/mammalian-target-of-rapamycin (mTOR) signaling axis were all evaluated in the presence of different concentrations of PEA and concomitant administration of PPAR-α and -γ antagonists. RESULTS: Our results demonstrated that PEA, in a selective peroxisome proliferator activated receptor (PPAR)-α dependent mechanism, inhibits colitis-associated angiogenesis, decreasing VEGF release and new vessels formation. Furthermore, we demonstrated that the mTOR/Akt axis regulates, at least partly, the angiogenic process in IBD and that PEA directly affects this pathway. CONCLUSIONS: Our results suggest that PEA may improve inflammation-driven angiogenesis in colonic mucosa, thus reducing the mucosal damage and potentially affecting disease progression and the shift towards the carcinogenesis.
format Online
Article
Text
id pubmed-4878779
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48787792016-06-09 Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner Sarnelli, Giovanni D’Alessandro, Alessandra Iuvone, Teresa Capoccia, Elena Gigli, Stefano Pesce, Marcella Seguella, Luisa Nobile, Nicola Aprea, Giovanni Maione, Francesco de Palma, Giovanni Domenico Cuomo, Rosario Steardo, Luca Esposito, Giuseppe PLoS One Research Article BACKGROUND AND AIM: Angiogenesis is emerging as a pivotal process in chronic inflammatory pathologies, promoting immune infiltration and prompting carcinogenesis. Ulcerative Colitis (UC) and Crohn’s Disease (CD) represent paradigmatic examples of intestinal chronic inflammatory conditions in which the process of neovascularization correlates with the severity and progression of the diseases. Molecules able to target the angiogenesis have thus the potential to synergistically affect the disease course. Beyond its anti-inflammatory effect, palmitoylethanolamide (PEA) is able to reduce angiogenesis in several chronic inflammatory conditions, but no data about its anti-angiogenic activity in colitis have been produced, yet. METHODS: The effects of PEA on inflammation-associated angiogenesis in mice with dextran sulphate sodium (DSS)-induced colitis and in patients with UC were assessed. The release of Vascular Endothelial Growth Factor (VEGF), the hemoglobin tissue content, the expression of CD31 and of phosphatidylinositol 3-kinase/Akt/mammalian-target-of-rapamycin (mTOR) signaling axis were all evaluated in the presence of different concentrations of PEA and concomitant administration of PPAR-α and -γ antagonists. RESULTS: Our results demonstrated that PEA, in a selective peroxisome proliferator activated receptor (PPAR)-α dependent mechanism, inhibits colitis-associated angiogenesis, decreasing VEGF release and new vessels formation. Furthermore, we demonstrated that the mTOR/Akt axis regulates, at least partly, the angiogenic process in IBD and that PEA directly affects this pathway. CONCLUSIONS: Our results suggest that PEA may improve inflammation-driven angiogenesis in colonic mucosa, thus reducing the mucosal damage and potentially affecting disease progression and the shift towards the carcinogenesis. Public Library of Science 2016-05-24 /pmc/articles/PMC4878779/ /pubmed/27219328 http://dx.doi.org/10.1371/journal.pone.0156198 Text en © 2016 Sarnelli et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sarnelli, Giovanni
D’Alessandro, Alessandra
Iuvone, Teresa
Capoccia, Elena
Gigli, Stefano
Pesce, Marcella
Seguella, Luisa
Nobile, Nicola
Aprea, Giovanni
Maione, Francesco
de Palma, Giovanni Domenico
Cuomo, Rosario
Steardo, Luca
Esposito, Giuseppe
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
title Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
title_full Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
title_fullStr Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
title_full_unstemmed Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
title_short Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner
title_sort palmitoylethanolamide modulates inflammation-associated vascular endothelial growth factor (vegf) signaling via the akt/mtor pathway in a selective peroxisome proliferator-activated receptor alpha (ppar-α)-dependent manner
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878779/
https://www.ncbi.nlm.nih.gov/pubmed/27219328
http://dx.doi.org/10.1371/journal.pone.0156198
work_keys_str_mv AT sarnelligiovanni palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT dalessandroalessandra palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT iuvoneteresa palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT capocciaelena palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT giglistefano palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT pescemarcella palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT seguellaluisa palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT nobilenicola palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT apreagiovanni palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT maionefrancesco palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT depalmagiovannidomenico palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT cuomorosario palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT steardoluca palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner
AT espositogiuseppe palmitoylethanolamidemodulatesinflammationassociatedvascularendothelialgrowthfactorvegfsignalingviatheaktmtorpathwayinaselectiveperoxisomeproliferatoractivatedreceptoralphapparadependentmanner